Sign In
Free Newsletter
Journal reports Maryland biotech company’s malaria vaccine as safe
Researchers from Rockville biotech company Sanaria Inc. and the National Institutes of Health (NIH) are making progress in the development of highly protective malaria vaccines.
Regenxbio to double workforce, receive state funding for new HQ
Biotech firm Regenxbio Inc. plans to double its workforce and will receive assistance from Maryland and Montgomery County for its previously-announced headquarters expansion in Rockville.
ABL helping biotech firm with process for vaccine development
ABL Inc., a biomedical contractor based in Rockville, is working to advance the development of a new vaccine platform.
Baltimore biotech firm launches kit for rapid DNA extraction
Circulomics Inc. recently launched a new kit that it said would let scientists more rapidly perform high-molecular-weight DNA extraction.
Stem cell work has Md. aiming to take advantage of biotech growth
The success of a Maryland fund dedicated to supporting research and commercialization around stem cells could help the state position itself for a biotech boom. The Maryland Stem Cell Research Fund has helped the state’s drive to be a biotechnology hub, according to an economic impact study sponsored by the Maryland Technology Development Corporation, which […]
Md. biopharm gets $1M NIH grant to study drug
Neuralstem Inc., a biopharmaceutical company, recently received a grant worth up to nearly $1 million from the National Institutes of Health. The Germantown company received the research grant, to evaluate over two years the ability of its small molecule compound, NSI-189 to prevent and treat diabetic neuropathy. In a previous study, NSI-189 was shown to significantly protect motor and sensor[...]
Md. biotech sees good results from respiratory virus vaccine trial
Novavax Inc., a Gaithersburg-based biotechnology company, on Tuesday announced that it had seen positive data from its phase 2 trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate. There is no approved vaccine for the virus, which is the most common cause of lower respiratory tract infections and the leading viral cause of severe lower respiratory […]
FDA approves first lower-cost biotech drug
Federal health officials on Friday approved the first lower-cost copy of a biotech drug in the U.S., a long-awaited milestone that could save billions for insurers, doctors and patients.
Google’s health startup forges venture with AbbVie
Google's ambitious health startup is teaming up with biotechnology drugmaker AbbVie in a $500 million joint venture that will try to develop new ways to treat cancer and other diseases such as Alzheimer's.
National Cancer Institute ends Md. lab mice deal
The National Cancer Institute is terminating its contract with a Frederick, Maryland supplier of hundreds of thousands of genetically engineered laboratory mice.
Gaithersburg-based FedMed expands access to cancer tests
BioTheranostics Inc., a San Diego-based provider of genomic-based tools for cancer diagnosis, said it signed a contract with Gaithersburg-based FedMed Inc., one of the largest preferred provider organization networks in the United States, to provide access to bioTheranostics’ genomic tests for patients with breast cancer and metastatic cancers.
$12M available for biotech investors
State officials are continuing their efforts to make biotechnology big business in Maryland.
